HopeStage
Back to all studies
UnknownNCT03472638

Dorsomedial rTMS For Depression In Borderline Personality Disorder

This study has public registry information. It focuses on personality disorders and currently lists study information in Canada.

Personality disorders, Depression, ...DeviceFrom 18 Years to 65 Years
The study in practice

Understand this study

What is this study about?

This study evaluates the effectiveness of transcranial magnetic stimulation for people with depression.

Who could participate?

Listed age limits: 18 years to 65 years.

Listed locations
Toronto, CanadaSee all locations and recruitment

Compensation and expense reimbursement have not been verified for this summary.

What to know before participating

A point to clarify

This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?

Study clarity

Things to check before joining

Study start dateStarted: July 2016
Recruitment status
Unknown
Enrollment listed in the registry
20
Sponsor
University Health Network, Toronto
Sponsor type
University
Study type
Device
Intervention type
DEVICE
Study phase
Not clearly listed
Locations
Canada
Age range
From 18 Years to 65 Years
Official registry ID
NCT03472638
Official title
Efficacy Of Repetitive Transcranial Magnetic Stimulation In The Treatment Of Refractory Depression Among Patients With Borderline Personality Disorder

Ask HopeStage to help me review this study

This record does not confirm open recruitment. We can help you understand it and explore other studies.

Loading the security check...
Study ID: NCT03472638. We help you review the study, but cannot decide medical eligibility.

Recruitment & locations

Status unknown

Toronto

Registry details
Registry conditions (original wording)

Borderline Personality Disorder; Major Depression

A listed location does not confirm current availability.

FAQ

Questions about this study

What is this study about?

This study evaluates the effectiveness of transcranial magnetic stimulation for people with depression.

Who is behind this study?

The study sponsor is University Health Network, Toronto, a university.

Who can participate?

Listed age limits: 18 years to 65 years.

Explore other studies

Want to find a study that may fit you better?

Answer a few simple questions to explore HopeStage studies by condition, country, and situation.

Find a study that may fit me